Alkermes awards $1M to support people affected by mental health
Alkermes, a global biopharmaceutical company developing medicines for the treatment of central nervous system…
Pharmaceuticals, Biotechnology and Life Sciences
Alkermes, a global biopharmaceutical company developing medicines for the treatment of central nervous system…
Allergan has completed its initial $5 billion in share repurchases under its previously announced share repurchase program…
Abzena has issued a statement in which it notes that during the conference call to accompany Gilead Sciences Inc.’s (‘Gilead’) announcement of third quarter
Chronix Biomedical looking to distinguish prostate cancer from BPH and prostatitis
Pfizer announced today the discontinuation of the global clinical development program for bococizumab…
Novartis gets FDA Priority Review for first-line treatment of HR+/HER2-advanced breast cancer
India’s Strides Shasun Limited has received approval from the USFDA for Abacavir Tablets
Mylan NV’s price hikes on EpiPens have added millions to U.S. Department of Defense spending…
BD has gotten FDA market authorization for a first-of-its-kind molecular test…